Browse Category

Stock Market News 17 October 2025

Novo Nordisk’s $5.2 Billion Bet to Reverse Fatty Liver Disease – Game-Changer or Big Gamble?

Novo Nordisk’s Weight-Loss Crown at Risk? NVO Stock Slumps Amid Surprise Deals – What’s Next

NVO Stock Slides as Weight-Loss Hype Cools Novo Nordisk’s stock has been on a wild ride. After becoming Europe’s most valuable company in 2022–2023 on the back of its smash-hit obesity drug Wegovy, the Danish pharma giant has seen its
Zions Bancorp Stock Plunges 13% After Surprise $50M Fraud-Linked Loan Loss – Is More Trouble Ahead?

Fraud Scandals at U.S. Banks Wipe $100 Billion, Spur Global Selloff as ‘Cockroach’ Credit Fears Mount

Fraud Shocks at Regional Lenders Ignite a Selloff This week’s drama began when Zions Bancorporation, a Utah-based regional bank, revealed a major loan fraud that blindsided investors. In an SEC filing on Oct. 15, Zions said it discovered “misrepresentations and
1 804 805 806 807 808 888
Go toTop